CARA Therapeutics Inc. (CARA)

19.13
NASDAQ : Health Technology
Prev Close 19.69
Day Low/High 18.95 / 19.61
52 Wk Low/High 12.19 / 27.55
Avg Volume 764.10K
Exchange NASDAQ
Shares Outstanding 46.59M
Market Cap 917.32M
EPS -2.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

There's No Big Rush for the Indices at this Point

There's No Big Rush for the Indices at this Point

The best way to deal with the struggling market is selective stock picking and good defense.

Using Market Softness to Add to Stocks Incrementally

Using Market Softness to Add to Stocks Incrementally

I think we'll probably see some shifting in the tariff policy over the weekend, giving the market some relief.

Being Patient Until I Can Trust This Market More

Being Patient Until I Can Trust This Market More

It is very easy to force trades in this sort of environment.

Focused on Two Sectors

Focused on Two Sectors

If we have a little consolidating action here the buyers will start pushing again.

Indexes Are Holding Up Well, For Now

Indexes Are Holding Up Well, For Now

There are signs of stabilization, but the market is still digesting some very big swings.

The Character of the Market Has Shifted

The Character of the Market Has Shifted

The big question right now is to what degree should you be looking to take positions in individual stocks you may like.

8 Stocks That Are Ready to Change Direction

8 Stocks That Are Ready to Change Direction

These names are displaying bullish and bearish reversal patters over the last week.

How Trading Notes Can Increase Your Profits

How Trading Notes Can Increase Your Profits

Inertia is your biggest enemy in this market.

Exelixis Pops on Phase 3 Data for Liver Cancer Drug -- Biotech Movers

Exelixis Pops on Phase 3 Data for Liver Cancer Drug -- Biotech Movers

The South San Francisco, Calif.-based company said Oct. 16 its Phase 3 study of cabozantinib achieved its primary endpoint of overall survival in patients that have advanced hepatocellular carcinoma.

Trump's FDA: A Friendlier Biotech Sheriff

Trump's FDA: A Friendlier Biotech Sheriff

There still will be winners and losers, but the new administration's FDA is a net plus for the industry.

These Stocks Are Changing Directions

These Stocks Are Changing Directions

Bullish and bearish reversals in the market.

Watching the Dip Buyers This Morning

Watching the Dip Buyers This Morning

It would be better from a trading standpoint for this market to sell off with some vigor.

CARA Mia!

"Cara Mia why must we say goodbye? Each time we part my heart wants to die Darling hear my prayer Cara Mia fair I'll be your love till the end of time..."   --Jay and the Americans, "Cara Mia"    I want to call everyone's attention to our Comments S...

Cannabis Culture and Whole Foods Speculation

Some minor improvement in the major indices from our last update. Market is almost to flat line as we approach the close of the week -- and June options expiration, as well. Whole Foods Market  is slightly above the $42 a share buyout offer from Ama...

Health Care Vote Impacts Trump's Deal Maker Image

Health Care Vote Impacts Trump's Deal Maker Image

At stake is whether the Republicans can work out their differences.

4 Small-Cap Biotech Stars

4 Small-Cap Biotech Stars

I'm still enthusiastic about the sector, but it is critical to also be prudent.

4 Small-Cap Biotech Stars

4 Small-Cap Biotech Stars

I'm still enthusiastic about the sector, but it is critical to also be prudent.

Market Action Is Boring but Necessary

Market Action Is Boring but Necessary

After yesterday's surprise pullback, this is the sort of consolidation we need.

Market Taking a Break, but Probably Not for Long

Market Taking a Break, but Probably Not for Long

Today is more about stock picking.

Why Cara Therapeutics Is Up, Trevena Down

Why Cara Therapeutics Is Up, Trevena Down

Readers want to know what to do with the two biotech names, which are headed in opposite directions.

Here Are 5 Stocks With Unusual Volume

Here Are 5 Stocks With Unusual Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst

Two Biopharma Names, Cara Therapeutics and Egalet, Rising

The market is extremely flat today as we hit midday. Equities are about as exciting right now as the Rams offense was just hours ago on Thursday Night Football. Two of my favorite small biopharma names, Egalet  and Cara Therapeutics , are on the way...

The Pockets of Speculative Action Have Dried Up

The Pockets of Speculative Action Have Dried Up

There simply aren't many compelling trades on my screen.

Cara Therapeutics on a Run

Not much change in the market since our last update. The S&P 500 and Dow are down, and the NASDAQ is having a nice day. Longtime favorite Cara Therapeutics continues its huge run, up another 20% plus today. But I can't find any new news to support t...

An Uninspired Start

And we are off. The market has opened opens slightly lower across the board. We're seeing some profit taking early on in stocks and sectors that have done extremely well since the election. United Rentals , after massive run over the past week, is d...

3 Biotech-Investing Mistakes to Avoid

3 Biotech-Investing Mistakes to Avoid

These are the biggest errors that I've made over the years.

This Is Just Routine Churning

This Is Just Routine Churning

We are still a bit extended and it isn't surprising to see a pause.

Minor Weakness Doesn't Deter Buyers

Minor Weakness Doesn't Deter Buyers

Market's junk stocks attract traders.